Seth M. Steinberg

Also affiliated with Office of the Director, National Cancer Institute, Center for Cancer Research

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

5in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 5 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Supplementary Figure from Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

(2023)10.1158/1078-0432.22486571

Top 100%

0DataRank

Top 100%0 citations

Scot A. Niglio, Amir Mortazavi, Rosa Nadal, Primo N. Lara, Sumanta K. Pal +30 more

Papers

Driven by 146 papers — median percentile 0. Top paper: “Selumetinib in Children with Inoperable Plexiform Neurofibromas”.

Selumetinib in Children with Inoperable Plexiform Neurofibromas

New England Journal of Medicine(2020)10.1056/nejmoa1912735

N/A

9.0DataRank · unranked

708 citations

Pamela L. Wolters, Eva Dombi, Andrea Baldwin, Patricia Whitcomb, Michael J. Fisher +24 more

Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL

Journal of Clinical Oncology(2021)10.1200/jco.20.02262

N/A

6.9DataRank · unranked

362 citations

Daniel W. Lee, Bonnie Yates, Constance M. Yuan, Haneen Shalabi, Staci Martin +9 more

Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma

Journal of Clinical Oncology(2020)10.1200/jco.20.00303

N/A

5.0DataRank · unranked

152 citations

Kieron Dunleavy, Jeremy S. Abramson, Bayard L. Powell, Brian K. Link, Prapti A. Patel +19 more

CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR

Blood(2022)10.1182/blood.2022015795

N/A

3.6DataRank · unranked

177 citations

Haiying Qin, Angela Su, Bonnie Yates, Pamela L. Wolters, Seth M. Steinberg +30 more

Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors

Journal of Clinical Oncology(2020)10.1200/jco.20.01652

N/A

3.5DataRank · unranked

138 citations

Rosa Nadal, Daniel M. Girardi, Scot A. Niglio, Lisa Ley, Lisa M. Cordes +30 more

Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial

The Lancet Oncology(2020)10.1016/s1470-2045(20)30202-3

N/A

3.0DataRank · unranked

89 citations

Rosa Nadal, Yusuke Tomita, Nicole N. Davarpanah, Lisa M. Cordes, Seth M. Steinberg +27 more

Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas

Neuro-Oncology(2023)10.1093/neuonc/noad086

N/A

2.3DataRank · unranked

97 citations

Eva Dombi, Pamela L. Wolters, Andrea Baldwin, Anne Dufek, Kailey R. Herrera +14 more

Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000655

N/A

1.8DataRank · unranked

77 citations

Jennifer L. Marté, Renee N. Donahue, Beatriz Walter-Rodriguez, Christopher R. Heery, Seth M. Steinberg +13 more

Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidity

Neuro-Oncology(2022)10.1093/neuonc/noac109

N/A

1.7DataRank · unranked

66 citations

Brittany Glassberg, Pamela L. Wolters, Eva Dombi, Andrea Baldwin, Michael J. Fisher +18 more

Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseases

Blood Advances(2021)10.1182/bloodadvances.2020004058

N/A

1.7DataRank · unranked

78 citations

Kathryn Lurain, Mark N. Polizzotto, Irene Ekwede, Kirsta Waldon, Seth M. Steinberg +14 more

Phase II study of selumetinib, an orally active inhibitor of MEK1 and MEK2 kinases, in KRASG12R-mutant pancreatic ductal adenocarcinoma

Investigational New Drugs(2021)10.1007/s10637-020-01044-8

N/A

1.6DataRank · unranked

46 citations

Tricia Kunst, Santhana Webb, Christina DeVisser, Christy Arrowood, Seth M. Steinberg +4 more

A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma

The Oncologist(2022)10.1093/oncolo/oyab073

N/A

1.5DataRank · unranked

44 citations

Erica C. Pehrsson, Changqing Xie, Austin G. Duffy, Donna Mabry, Bradford J. Wood +10 more

Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma

New England Journal of Medicine(2024)10.1056/nejmoa2401532

N/A

1.5DataRank · unranked

68 citations

Rahul Lakhotia, Stefania Pittaluga, James D. Phelan, Da Wei Huang, George W. Wright +31 more

Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-005640

N/A

1.4DataRank · unranked

72 citations

Changqing Xie, Yuta Myojin, Kelley Coffman, Donna Mabry Hrones, Sophie Wang +15 more

Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma

JAMA Oncology(2021)10.1001/jamaoncol.2021.3971

N/A

1.3DataRank · unranked

45 citations

Elizabeth Hill, Alexander Dew, Candis Morrison, Joseph Roswarski, Neha Korde +29 more

Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma

Blood Advances(2022)10.1182/bloodadvances.2021006397

N/A

1.3DataRank · unranked

44 citations

Christopher Melani, Kieron Dunleavy, Stefania Pittaluga, Nakhle S. Saba, Liza Lindenberg +11 more

A phase II trial of the super-enhancer inhibitor Minnelide™ in advanced refractory adenosquamous carcinoma of the pancreas

Future Oncology(2022)10.2217/fon-2021-1609

N/A

1.1DataRank · unranked

43 citations

Mehwish Ahmad, Seth M. Steinberg, Jane B. Trepel, Derek Cridebring, Haiyong Han +3 more

Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3726

N/A

1.1DataRank · unranked

24 citations

Scot A. Niglio, Amir Mortazavi, Rosa Nadal, Primo Lara, Sumanta K. Pal +30 more

Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer

JAMA Oncology(2023)10.1001/jamaoncol.2023.4025

N/A

1.1DataRank · unranked

48 citations

Zhonglin Hao, Liza C. Villaruz, Jun Zhang, Jimmy Ruiz, W. Jeffrey Petty +33 more

Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant

Blood Advances(2021)10.1182/bloodadvances.2021005039

N/A

0.937DataRank · unranked

28 citations

Evgeny Arons, Maryalice Stetler‐Stevenson, Constance M. Yuan, Hao‐Wei Wang, Hong Zhou +13 more

A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2168

N/A

0.815DataRank · unranked

22 citations

R. Taylor Sundby, Mary Frances Wedekind, Fernanda I. Arnaldez, Jaydira Del Rivero, Lori Wiener +27 more

Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells

Blood(2021)10.1182/blood.2021011898

N/A

0.789DataRank · unranked

192 citations

Fiorella Schischlik, Lipei Shao, Seth M. Steinberg, Bonnie Yates, Hao‐Wei Wang +25 more

Intermediate-dose posttransplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantation

Blood Advances(2025)10.1182/bloodadvances.2024014879

N/A

0.783DataRank · unranked

24 citations

Dimana Dimitrova, Ruby Sabina, Ashley DeVries, Jeannine S. McCune, Meredith J. McAdams +17 more

Factors Impacting Overall and Event-Free Survival following Post-Chimeric Antigen Receptor T Cell Consolidative Hematopoietic Stem Cell Transplantation

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.10.011

N/A

0.770DataRank · unranked

19 citations

Seth M. Steinberg, Bonnie Yates, Daniel W. Lee, Lauren Little, Crystal L. Mackall +3 more

Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells

Blood Advances(2022)10.1182/bloodadvances.2022007423

N/A

0.749DataRank · unranked

146 citations

Regina M. Myers, Agne Taraseviciute, Samuel John, Bonnie Yates, Seth M. Steinberg +24 more

Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0709

N/A

0.652DataRank · unranked

20 citations

R. Taylor Sundby, Donna Bernstein, John Glod, Rosandra N. Kaplan, Marielle E. Yohe +17 more

Phase 1 study of the immunotoxin LMB‐100 in patients with mesothelioma and other solid tumors expressing mesothelin

Cancer(2020)10.1002/cncr.33145

N/A

0.621DataRank · unranked

62 citations

Christine Alewine, Idrees Mian, Anna Spreafico, Lillian L. Siu, Carlos Gomez‐Roca +13 more

Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexate

Blood(2020)10.1182/blood.2020006048

N/A

0.574DataRank · unranked

45 citations

Thomas S. Uldrick, Ramya Ramaswami, Mark N. Polizzotto, Priscila Gonçalves, Anaida Widell +12 more

Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy

Blood Advances(2022)10.1182/bloodadvances.2022008093

N/A

0.533DataRank · unranked

34 citations

Regina M. Myers, Bonnie Yates, Colleen Annesley, Samuel John, Agne Taraseviciute +17 more

Clinical value of 18FDG PET/MRI in muscle-invasive, locally advanced, and metastatic bladder cancer

Urologic Oncology Seminars and Original Investigations(2021)10.1016/j.urolonc.2021.04.024

N/A

0.515DataRank · unranked

30 citations

Scot A. Niglio, Ashkan A. Malayeri, Jeffrey Lin, Sandeep Gurram, Heather J. Chalfin +5 more

Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trial

The Lancet Haematology(2023)10.1016/s2352-3026(23)00029-7

N/A

0.493DataRank · unranked

14 citations

Kennichi Dowdell, Stefania Pittaluga, Kieron Dunleavy, Mark Roschewski, Joo Y. Song +11 more

Phase II study of olaparib in malignant mesothelioma (MM) to correlate efficacy with germline and somatic mutations in DNA repair genes.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9054

N/A

0.470DataRank · unranked

22 citations

Idrees Mian, Cathy Wagner, Yvonne Mallory, Maria Agra, Emerson Padiernos +8 more

VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008079

N/A

0.470DataRank · unranked

11 citations

Yuta Myojin, Cecilia Monge, Changqing Xie, Donna Mabry Hrones, Bradford J. Wood +7 more

High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention

Blood Advances(2024)10.1182/bloodadvances.2023010973

N/A

0.451DataRank · unranked

11 citations

Lauren M. Curtis, Rachel B. Salit, Brian C. Shaffer, Filip Pirsl, Alen Ostojić +14 more

Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma

Cancer Medicine(2024)10.1002/cam4.6912

N/A

0.450DataRank · unranked

12 citations

Changqing Xie, Yuta Myojin, Kelley Coffman, Donna Mabry Hrones, Gagandeep Brar +12 more

A phase I/II study of Pexa-Vec oncolytic virus in combination with immune checkpoint inhibition in refractory colorectal cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.117

N/A

0.449DataRank · unranked

19 citations

Changqing Xie, Seth M. Steinberg, Suzanne Fioraventi, Melissa Walker, Donna Mabry‐Hrones +4 more

Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers

Frontiers in Oncology(2024)10.3389/fonc.2024.1386190

N/A

0.421DataRank · unranked

9 citations

Cody J. Peer, Xianyu Zhang, Hyoyoung Choo‐Wosoba, Mehwish Ahmad, Min-Jung Lee +13 more

Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2145

N/A

0.416DataRank · unranked

15 citations

Naoko Takebe, Shivaani Kummar, Albiruni R. Abdul Razak, Sant P. Chawla, Suzanne George +13 more

Anakinra for refractory pustular psoriasis: A phase II, open-label, dose-escalation trial

Journal of the American Academy of Dermatology(2022)10.1016/j.jaad.2022.07.065

N/A

0.416DataRank · unranked

15 citations

Dominique C. Pichard, Daniella M. Schwartz, Michelle O’Brien, Matthew Masciocchi, Julie Thompson +12 more

Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell Failure

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.06.019

N/A

0.370DataRank · unranked

6 citations

Bonnie Yates, Seth M. Steinberg, Constance M. Yuan, Hao‐Wei Wang, Colleen Annesley +11 more

Metabolic syndrome prevalence and impact on outcomes in patients with chronic graft-versus-host disease

Bone Marrow Transplantation(2023)10.1038/s41409-023-02097-y

N/A

0.333DataRank · unranked

7 citations

Filip Pirsl, Seth M. Steinberg, Noa G. Holtzman, Eduard Schulz, Alain Mina +7 more

Clinical characterization and cytokine profile of fatigue in hematologic malignancy patients with chronic graft-versus-host disease

Bone Marrow Transplantation(2021)10.1038/s41409-021-01419-2

N/A

0.312DataRank · unranked

7 citations

Leorey N. Saligan, Filip Pirsl, Noa G. Holtzman, Alen Ostojić, Seth M. Steinberg +9 more

First-in-human phase I/II trial of PRGN-2009 vaccine as monotherapy or with bintrafusp alfa in patients with recurrent/metastatic (R/M) human papillomavirus (HPV)-associated cancers (HPVC) and as neoadjuvant/induction therapy in locoregionally advanced (LA) HPV oropharyngeal (OP) and sinonasal (SN) squamous cell cancer (SCC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps6092

N/A

0.245DataRank · unranked

3 citations

Julius Strauss, Clint Allen, Nyall R. London, Renee N. Donahue, Caroline Jochéms +14 more

Predictors and significance of kidney dysfunction in patients with chronic graft-versus-host disease

Bone Marrow Transplantation(2023)10.1038/s41409-023-02032-1

N/A

0.215DataRank · unranked

2 citations

Filip Pirsl, Noa G. Holtzman, Seth M. Steinberg, Jacqueline W. Mays, Edward W. Cowen +7 more

A comprehensive analysis of adverse events in the first 30 days of phase 1 pediatric CAR T-cell trials

Blood Advances(2023)10.1182/bloodadvances.2023009789

N/A

0.177DataRank · unranked

2 citations

Sanna Madan, Elizabeth M. Holland, Seth M. Steinberg, Lauren Little, Toni Foley +10 more

A phase II study of lurbinectedin with or without avelumab in small cell carcinoma of the bladder (laser)—design and rationale

Future Oncology(2025)10.1080/14796694.2025.2480534

N/A

0.165DataRank · unranked

2 citations

Elias Chandran, Saad Atiq, Andre R. Kydd, Daniel M. Girardi, Lisa Ley +14 more

Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e16158

N/A

0.165DataRank · unranked

2 citations

Kelley Coffman, Donna Mabry Hrones, Seth M. Steinberg, Bernadette Redd, Bradford J. Wood +3 more

Venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide (ViPOR) in relapsed/refractory (R/R) and treatment‐naïve (TN) mantle cell lymphoma (MCL)

Hematological Oncology(2023)10.1002/hon.3164_437

N/A

0.104DataRank · unranked

1 citations

Rahul Lakhotia, Stefania Pittaluga, J. D. Phelan, Y. Yang, Theresa Davies‐Hill +17 more

A Phase II Pilot Study of Anti‐ PD ‐ L1 , Durvalumab, and a PARP Inhibitor, Olaparib in Patients With Metastatic Triple‐Negative Breast Cancer With or Without Germline BRCA Mutation

Cancer Medicine(2025)10.1002/cam4.71220

N/A

0.104DataRank · unranked

1 citations

Ashley Cimino‐Mathews, Stanley Lipkowitz, Min-Jung Lee, Jayakumar R. Nair, B. Brooke Solarz +9 more

Red cell distribution width as a new prognostic biomarker in refractory chronic graft-versus-host disease

Haematologica(2023)10.3324/haematol.2023.283646

N/A

0.104DataRank · unranked

1 citations

Filip Pirsl, Noa G. Holtzman, David Beshensky, Edward W. Cowen, Sandra A. Mitchell +3 more

Extended progression-free survival and long-term safety of nirogacestat in patients with desmoid tumors.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.11545

N/A

0DataRank · unranked

5 citations

Shivaani Kummar, Seth M. Steinberg, Murielle Hogu, Naoko Takebe, Amisha Shah +3 more

Results of a phase I trial of ganitumab plus dasatinib in patients with rhabdomyosarcoma (RMS).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.11561

N/A

0DataRank · unranked

4 citations

Donna Bernstein, John Glod, Rosandra N. Kaplan, John Shern, Marielle E. Yohe +14 more

Durvalumab (D) in combination with olaparib (O) for advanced, previously treated non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e21153

N/A

0DataRank · unranked

3 citations

Rasa Vilimas, Cristina Mullenix, Chen Zhao, Éva Szabó, Meenakshi Shelat +6 more

Targeting genomic instability in extrapulmonary small cell neuroendocrine cancers: A phase II study with ATR inhibitor berzosertib and topotecan.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.8518

N/A

0DataRank · unranked

3 citations

Parth Desai, Linda Sciuto, Samantha Nichols, Seth M. Steinberg, Anish Thomas +1 more

The association of FDG PET/CT and NaF PET/CT with survival outcomes in patients (pts) with metastatic genitourinary malignancies (mGU) treated with cabozantinib + nivolumab +/- ipilimumab (CaboNivo +/- Ipi).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.452

N/A

0DataRank · unranked

0 citations

Katherine Lei, Nicholas Peter Verdini, Jeffrey Lin, Andy Vega, Scot A. Niglio +13 more

557 The epitope-enhanced TARP peptide can induce specific T cells that can recognize wild-type TARP tetramer by either peptide or peptide-pulsed DC vaccination in patients with prostate cancer

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0557

N/A

0DataRank · unranked

0 citations

Refika Turnier, Kimberly Dunham, Masaki Terabe, Seth M. Steinberg, Brenda Roberson +6 more

Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-0855

N/A

0DataRank · unranked

23 citations

Wei Zhang, Seth M. Steinberg, Darryl Nousome, Nicole Houston, Xiaolin Wu +22 more

Bridging Health Disparities: a Genomics and Transcriptomics Analysis by Race in Prostate Cancer

Journal of Racial and Ethnic Health Disparities(2023)10.1007/s40615-023-01534-4

N/A

0DataRank · unranked

7 citations

Erica L. Beatson, Seth M. Steinberg, Cindy H. Chau, Douglas K. Price, William D. Figg +1 more

AB016. Phase 2 clinical trial of PT-112 in patients with thymic epithelial tumors

Mediastinum(2023)10.21037/med-23-ab016

N/A

0DataRank · unranked

3 citations

Shannon Swift, Renee N. Donahue, Carolina Celades, Yo-Ting Tsai, Molly A. Bingham +14 more

Phase I evaluation of PRGN-2009 alone and in combination with bintrafusp alfa in patients (pts) with recurrent/metastatic (R/M) HPV-associated cancers (HPV-C).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.2628

N/A

0DataRank · unranked

11 citations

Julius Strauss, Jason M. Redman, Danielle M. Pastor, Evrim Türkbey, Renee N. Donahue +11 more

A phase II study of olaparib (AZD2281) in patients (Pts) with metastatic/advanced urothelial carcinoma and other genitourinary (GU) tumors with DNA-repair defects.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps4607

N/A

0DataRank · unranked

3 citations

Nicholas I. Simon, Scot A. Niglio, Lisa Ley, Lisa M. Cordes, Rouf Banday +15 more

781 A phase II, open-label trial of bintrafusp alfa (M7824) in subjects with thymoma and thymic carcinoma (trial in progress)

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.0781

N/A

0DataRank · unranked

2 citations

Shannon Swift, Renee N. Donahue, Carolina Celades, Yo-Ting Tsai, Molly A. Bingham +11 more

Phase 2 study of bintrafusp alfa in recurrent/metastatic olfactory neuroblastoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps6116

N/A

0DataRank · unranked

1 citations

Nyall R. London, Marissa Mallek, Lisa M. Cordes, Seth M. Steinberg, Jenn Marte +7 more

Data from Nm23-H1 Suppresses Metastasis by Inhibiting Expression of the Lysophosphatidic Acid Receptor EDG2

(2023)10.1158/0008-5472.c.6496434.v1

N/A

0DataRank · unranked

0 citations

Arnulfo Mendoza, Eleazar Vega-Valle, Mary Albaugh, Cari Graff‐Cherry, William G. McDermott +6 more

Supplementary Figure from Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

(2023)10.1158/1078-0432.22486571

Top 100%

0DataRank

Top 100%0 citations

Scot A. Niglio, Amir Mortazavi, Rosa Nadal, Primo N. Lara, Sumanta K. Pal +30 more

Supplementary Figure from Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

Figshare(2023)10.1158/1078-0432.22486556.v1

Top 100%

0DataRank

Top 100%0 citations

Scot A. Niglio, Amir Mortazavi, Rosa Nadal, Primo N. Lara, Sumanta K. Pal +30 more

Data from Safety, Activity, and Long-term Outcomes of Pomalidomide in the Treatment of Kaposi Sarcoma among Individuals with or without HIV Infection

(2023)10.1158/1078-0432.c.6532323.v1

N/A

0DataRank · unranked

0 citations

Mark N. Polizzotto, Kathryn Lurain, Kathleen M. Wyvill, Anaida Widell, Jomy George +6 more

Data from Safety, Activity, and Long-term Outcomes of Pomalidomide in the Treatment of Kaposi Sarcoma among Individuals with or without HIV Infection

(2023)10.1158/1078-0432.c.6532323

N/A

0DataRank · unranked

0 citations

Mark N. Polizzotto, Kathryn Lurain, Kathleen M. Wyvill, Anaida Widell, Jomy George +6 more

Data from A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer

(2023)10.1158/1078-0432.c.6519708.v1

N/A

0DataRank · unranked

0 citations

Kwong-Yok Tsang, Ravi A. Madan, Ngar‐Yee Huen, Diane J. Poole, Caroline Jochéms +12 more

Supplementary Table 1 from Phase I Trial of Adoptive Cell Transfer with Mixed-Profile Type-I/Type-II Allogeneic T Cells for Metastatic Breast Cancer

(2023)10.1158/1078-0432.22443327

Top 100%

0DataRank

Top 100%0 citations

Miriam E. Mossoba, Seth M. Steinberg, Vicki Fellowes, Xiaoyi Yan, Frances T. Hakim +14 more

Data from A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer

(2023)10.1158/1078-0432.c.6519708

N/A

0DataRank · unranked

0 citations

Kwong-Yok Tsang, Ravi A. Madan, Ngar‐Yee Huen, Diane J. Poole, Caroline Jochéms +12 more

Data from Phase I Trial of Adoptive Cell Transfer with Mixed-Profile Type-I/Type-II Allogeneic T Cells for Metastatic Breast Cancer

(2023)10.1158/1078-0432.c.6519780.v1

N/A

0DataRank · unranked

0 citations

Miriam E. Mossoba, Seth M. Steinberg, Vicki Fellowes, Xiaoyi Yan, Frances T. Hakim +14 more

Supplementary Table 1 from Phase I Trial of Adoptive Cell Transfer with Mixed-Profile Type-I/Type-II Allogeneic T Cells for Metastatic Breast Cancer

INDIGO (University of Illinois at Chicago)(2023)10.1158/1078-0432.22443327.v1

Top 100%

0DataRank

Top 100%0 citations

Miriam E. Mossoba, Seth M. Steinberg, Vicki Fellowes, Xiaoyi Yan, Frances T. Hakim +14 more

Data from Gene Expression Profile and Angiogenic Markers Correlate with Response to Neoadjuvant Bevacizumab Followed by Bevacizumab plus Chemotherapy in Breast Cancer

(2023)10.1158/1078-0432.c.6516904

N/A

0DataRank · unranked

0 citations

Seth M. Steinberg, Dat Tien Nguyen, Thomas D. Wu, Zora Modrušan, Sandra M. Swain +1 more

Data from Impact of ABCB1 Allelic Variants on QTc Interval Prolongation

(2023)10.1158/1078-0432.c.6518514

N/A

0DataRank · unranked

0 citations

Erin R. Gardner, Richard Piekarz, Reuben Howden, Xiaohong Chen, Sukyung Woo +14 more

Data from A Pharmacodynamic Study of Docetaxel in Combination with the P-glycoprotein Antagonist Tariquidar (XR9576) in Patients with Lung, Ovarian, and Cervical Cancer

(2023)10.1158/1078-0432.c.6519969

N/A

0DataRank · unranked

0 citations

Deborah Draper, Clara C. Chen, Robert W. Robey, William D. Figg, Richard Piekarz +8 more

Data from Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary Cancer

(2023)10.1158/1078-0432.c.6529986

N/A

0DataRank · unranked

0 citations

Tiziano Pramparo, Amir Mortazavi, Scot A. Niglio, Joseph D. Schonhoft, Adam Jendrisak +26 more

Data from Gene Expression Profile and Angiogenic Markers Correlate with Response to Neoadjuvant Bevacizumab Followed by Bevacizumab plus Chemotherapy in Breast Cancer

(2023)10.1158/1078-0432.c.6516904.v1

N/A

0DataRank · unranked

0 citations

Seth M. Steinberg, Dat Tien Nguyen, Thomas D. Wu, Zora Modrušan, Sandra M. Swain +1 more

Data from Pilot Study of Vaccination with Recombinant CEA-MUC-1-TRICOM Poxviral-Based Vaccines in Patients with Metastatic Carcinoma

(2023)10.1158/1078-0432.c.6517102.v1

N/A

0DataRank · unranked

0 citations

Philip M. Arlen, Kwong-Yok Tsang, Junko Yokokawa, Claudia Palena, Diane J. Poole +11 more

Data from Impact of ABCB1 Allelic Variants on QTc Interval Prolongation

(2023)10.1158/1078-0432.c.6518514.v1

N/A

0DataRank · unranked

0 citations

Erin R. Gardner, Richard Piekarz, Reuben Howden, Xiaohong Chen, Sukyung Woo +14 more

Data from A Pharmacodynamic Study of Docetaxel in Combination with the P-glycoprotein Antagonist Tariquidar (XR9576) in Patients with Lung, Ovarian, and Cervical Cancer

(2023)10.1158/1078-0432.c.6519969.v1

N/A

0DataRank · unranked

0 citations

Deborah Draper, Clara C. Chen, Robert W. Robey, William D. Figg, Richard Piekarz +8 more

Data from Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

(2023)10.1158/1078-0432.c.6532346.v1

Top 100%

0DataRank

Top 100%0 citations

Scot A. Niglio, Amir Mortazavi, Rosa Nadal, Primo N. Lara, Sumanta K. Pal +30 more

Data from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group

(2023)10.1158/1078-0432.c.6532878.v1

N/A

0DataRank · unranked

0 citations

Hyun Jung, G. Thomas Brown, Yanling Liu, Ben Somerville, Curtis Lisle +20 more

Final results from a phase 1 trial and expansion cohorts of cabozantinib and nivolumab alone or with ipilimumab for advanced/metastatic genitourinary tumors

Research Square(2023)10.21203/rs.3.rs-2924051/v1

N/A

0DataRank · unranked

0 citations

Scot A. Niglio, Rosa Nadal, Andre R. Kydd, Nicholas I. Simon, Lisa Ley +36 more

FDG PET/CT and NaF PET/CT imaging quantification of osseous metastatic lesions in patients with metastatic genitourinary (mGU) cancer and their association with survival outcomes.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e16573

N/A

0DataRank · unranked

0 citations

Nicholas I. Simon, Elias Chandran, Katherine Lei, Nicholas Peter Verdini, Jeffrey Lin +15 more

Comparison of peripheral blood markers in predicting the occurrence of immune-related adverse events in patients with metastatic genitourinary cancer treated with cabozantinib + nivolumab +/- ipilimumab.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e16506

N/A

0DataRank · unranked

0 citations

Elias Chandran, Nicholas I. Simon, Lisa Ley, Lisa M. Cordes, Tzu-fang Wang +13 more

Development and pilot validation of a novel disfigurement severity scale for plexiform neurofibromas in children with neurofibromatosis type 1

Clinical Trials(2023)10.1177/17407745231206402

N/A

0DataRank · unranked

0 citations

Gurbani Singh, Eva Dombi, Pamela L. Wolters, Staci Martin, Andrea Baldwin +14 more

1413 Immunogenicity of SARS-CoV-2 mRNA vaccines in individuals with thymic epithelial tumors

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.1413

N/A

0DataRank · unranked

0 citations

Hanna S Loving, Shannon Swift, Meredith J. McAdams, Chen Zhao, Éva Szabó +8 more

Hematopoietic cell transplantation for DOCK8 deficiency: Results from a prospective clinical trial

Journal of Allergy and Clinical Immunology(2024)10.1016/j.jaci.2024.08.021

N/A

0DataRank · unranked

9 citations

Corina Gonzalez, Bonnie Yates, Kristen Cole, Lauren Little, Erin Flannelly +18 more

1631P Results from the quick efficacy seeking trial (QuEST1) arm combining BN-brachyury (BNVax) + bintrafusp alfa (BA) + nogapendekin alfa inbakicept-pmln (N-803) in castration-resistant prostate cancer (CRPC)

Annals of Oncology(2024)10.1016/j.annonc.2024.08.1712

N/A

0DataRank · unranked

3 citations

Ravi A. Madan, Fatima Karzai, Lisa M. Cordes, Jenn Marte, N. Williams +9 more

Pharmacokinetics and pharmacogenomics of ribociclib in black patients with metastatic breast cancer the LEANORA study

npj Breast Cancer(2024)10.1038/s41523-024-00692-w

N/A

0DataRank · unranked

1 citations

Dylan M. Smith, Cody Peer, Tristan M. Sissung, Keith T. Schmidt, Ming Tan +16 more

Pulmonary Metastasectomy for Adrenocortical Carcinoma—Not If, but When

Cancers(2024)10.3390/cancers16040702

N/A

0DataRank · unranked

1 citations

F Hernandez, Diana Grace Varghese, Hyoyoung Choo‐Wosoba, Seth M. Steinberg, Martha E. Teke +4 more

Pharmacokinetics and Pharmacogenomics of Ribociclib in Black Patients with Metastatic Breast Cancer: The LEANORA study

Research Square(2024)10.21203/rs.3.rs-4656461/v1

N/A

0DataRank · unranked

0 citations

Ilana Schlam, Dylan M. Smith, Cody Peer, Tristan M. Sissung, Keith T. Schmidt +16 more

ATM-deficient murine thymic T-cell lymphoblastic lymphomas are PTEN-deficient and require AKT signaling for survival

PLoS ONE(2024)10.1371/journal.pone.0312864

N/A

0DataRank · unranked

0 citations

Karen S. Hathcock, Seth M. Steinberg, Hyoyoung Choo‐Wosoba, Richard J. Hodes, J. An

Tumor-targeted top1 inhibitor delivery with optimized parp inhibition in advanced solid tumors: a phase i trial of gapped scheduling

Nature Communications(2025)10.1038/s41467-025-64509-5

N/A

0DataRank · unranked

3 citations

Nobuyuki Takahashi, Lenka Oplustil O’Connor, Christophe E. Redon, Chirayu Mohindroo, Linda Sciuto +8 more

Primary Effusion Lymphoma Prognostic Score (PEL‐PS): A Validated International Prognostic Score in HIV‐Associated Primary Effusion Lymphoma

American Journal of Hematology(2025)10.1002/ajh.27580

N/A

0DataRank · unranked

5 citations

Ramya Ramaswami, Éric Oksenhendler, David Boutboul, Alessia Dalla Pria, Lara Ulrich +7 more

Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R

Blood Advances(2023)10.1182/bloodadvances.2023010223

N/A

0DataRank · unranked

0 citations

Kieron Dunleavy, Jeremy S. Abramson, Brian K. Link, Bayard L. Powell, Christopher Melani +10 more

Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0056

N/A

0DataRank · unranked

224 citations

Alexandra S. Zimmer, Michelle R. Padget, Ashley Cimino‐Mathews, Jayakumar R. Nair, Yingmiao Liu +13 more

Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3624

N/A

0DataRank · unranked

101 citations

Austin G. Duffy, Gagandeep Brar, Suzanne Fioravanti, Donna Mabry‐Hrones, Melissa Walker +14 more

Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2891

N/A

0DataRank · unranked

48 citations

Tiziano Pramparo, Amir Mortazavi, Scot A. Niglio, Joseph D. Schonhoft, Adam Jendrisak +26 more

Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus–associated multicentric Castleman disease

Blood(2020)10.1182/blood.2019004602

N/A

0DataRank · unranked

51 citations

Kathryn Lurain, Cody J. Peer, Anna Serquiña, Victoria Wang, Anaida Widell +10 more

Gene Expression Profiling of Mediastinal Gray Zone Lymphoma and Its Relationship to Primary Mediastinal B-cell Lymphoma and Classical Hodgkin Lymphoma

Blood Cancer Discovery(2020)10.1158/2643-3230.bcd-20-0009

N/A

0DataRank · unranked

48 citations

Alina Nicolae, George W. Wright, Christopher Melani, Mark Roschewski, Seth M. Steinberg +5 more

Characteristics of Matriculants to Thoracic Surgery Residency Training Programs

The Annals of Thoracic Surgery(2020)10.1016/j.athoracsur.2020.12.017

N/A

0DataRank · unranked

16 citations

Laurence P. Diggs, Sean P. Martin, Michael M. Wach, Mohammad Jafferji, Seth M. Steinberg +6 more

Clinical characteristics and cytokine biomarkers in patients with chronic graft‐vs‐host disease persisting seven or more years after diagnosis

American Journal of Hematology(2020)10.1002/ajh.25717

N/A

0DataRank · unranked

13 citations

Annie Im, Liang Cao, Filip Pirsl, Seth M. Steinberg, Lauren M. Curtis +10 more

Phase 2 Study of Seviteronel (INO-464) in Patients With Metastatic Castration-Resistant Prostate Cancer After Enzalutamide Treatment

Clinical Genitourinary Cancer(2020)10.1016/j.clgc.2019.11.002

N/A

0DataRank · unranked

17 citations

Keith T. Schmidt, Fatima Karzai, Cody J. Peer, Lisa M. Cordes, Cindy H. Chau +8 more

Cabozantinib plus docetaxel and prednisone in metastatic castration‐resistant prostate cancer

British Journal of Urology(2020)10.1111/bju.15227

N/A

0DataRank · unranked

13 citations

Fatima Karzai, Munjid Al Harthy, Daniel P. Petrylak, Joseph W. Kim, Philip M. Arlen +22 more

Evaluation of Factors Associated With Successful Matriculation to Colon and Rectal Surgery Fellowship

Diseases of the Colon & Rectum(2020)10.1097/dcr.0000000000001849

N/A

0DataRank · unranked

12 citations

Amy R. Copeland, Shreya Gupta, Seth M. Steinberg, Scott R. Steele, Heather Yeo +3 more

Enhanced efficacy of mesothelin-targeted immunotoxin LMB-100 and anti–PD-1 antibody in patients with mesothelioma and mouse tumor models

Science Translational Medicine(2020)10.1126/scitranslmed.aaz7252

N/A

0DataRank · unranked

44 citations

Azam Ghafoor, Idrees Mian, Daniel Rathkey, Anish Thomas, Christine Alewine +8 more

Phase II trial of bevacizumab and sorafenib in recurrent ovarian cancer patients with or without prior-bevacizumab treatment

Gynecologic Oncology(2020)10.1016/j.ygyno.2020.07.031

N/A

0DataRank · unranked

31 citations

Christina M. Annunziata, John L. Hays, Liang Cao, Peter L. Choyke, Minshu Yu +8 more

Pediatric PK/PD Phase I Trial of Pexidartinib in Relapsed and Refractory Leukemias and Solid Tumors Including Neurofibromatosis Type I–Related Plexiform Neurofibromas

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1696

N/A

0DataRank · unranked

30 citations

John Glod, Melissa Spencer, Miki Kasai, Joanne Derdak, Eva Dombi +9 more

Intravenous 5-fluoro-2′-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced solid tumors

Cancer Chemotherapy and Pharmacology(2020)10.1007/s00280-020-04073-5

N/A

0DataRank · unranked

26 citations

Lihua Wang, Jennifer Zlott, Lamin Juwara, Joseph M. Covey, Jan H. Beumer +18 more

A randomized, double-blind, phase II clinical trial of GI-6301 (yeast-brachyury vaccine) versus placebo in combination with standard of care definitive radiotherapy in locally advanced, unresectable, chordoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.11527

N/A

0DataRank · unranked

9 citations

Marijo Bilušić, Deric Park, Christopher R. Heery, Ravi A. Madan, Julius Strauss +7 more

PSA progression compared to radiographic or clinical progression in metastatic castration-resistant prostate cancer patients treated with enzalutamide.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.105

N/A

0DataRank · unranked

7 citations

Fatima Karzai, Jennifer L. Marté, Marijo Bilušić, Sheri McMahon, Julius Strauss +10 more

A phase I trial of pomalidomide in combination with liposomal doxorubicin in patients with Kaposi sarcoma with or without other KSHV-associated diseases.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.11552

N/A

0DataRank · unranked

7 citations

Kathryn Lurain, Anaida Widell, Priscila Gonçalves, Irene Ekwede, William D. Figg +9 more

A phase II trial of the DNA methyl transferase inhibitor, SGI-110 (Guadecitabine), in children and adults with SDH-deficient GIST, pheochromocytoma, and paraganglioma, and HLRCC-associated kidney cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.11540

N/A

0DataRank · unranked

5 citations

Jaydira Del Rivero, Fernanda I. Arnaldez, Ramaprasad Srinivasan, Melissa Spencer, Seth M. Steinberg +8 more

Phase II study of nivolumab (anti-PD1), tadalafil, and oral vancomycin in patients with refractory primary hepatocellular carcinoma or liver dominant metastatic cancer from colorectal or pancreatic cancers.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps4656

N/A

0DataRank · unranked

4 citations

Changqing Xie, Donna Mabry‐Hrones, Bradford J. Wood, Seth M. Steinberg, David E. Kleiner +2 more

Ipilimumab challenge/re-challenge in metastatic urothelial carcinoma (mUC) and other genitourinary (GU) tumors treated with cabozantinib+nivolumab (CaboNivo) or cabozantinib+nivolumab+ipilimumab (CaboNivoIpi).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.5039

N/A

0DataRank · unranked

3 citations

Daniel M. Girardi, Amir Mortazavi, Primo N. Lara, Sumanta K. Pal, Biren Saraiya +15 more

Phase I expansion study of cabozantinib plus nivolumab (CaboNivo) in metastatic urothelial carcinoma (mUC) patients (pts) with progressive disease following immune checkpoint inhibitor (ICI) therapy.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.5037

N/A

0DataRank · unranked

2 citations

Scot A. Niglio, Amir Mortazavi, Primo Lara, Sumanta K. Pal, Biren Saraiya +15 more

Phase I study of mesothelin-targeted immunotoxin LMB-100 given as a long infusion with or without nab-paclitaxel.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3553

N/A

0DataRank · unranked

2 citations

Mehwish Ahmad, Yunkai Yu, Akira Yuno, Min-Jung Lee, Cody J. Peer +8 more

Evaluating biomarkers in metastatic castration-resistant prostate cancer patients treated with enzalutamide: PSA, circulating tumor cell counts, AR-V7 status and radiographic progression.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e17569

N/A

0DataRank · unranked

1 citations

Fatima Karzai, Jennifer L. Marté, Marijo Bilušić, Sheri McMahon, Julius Strauss +13 more

Twenty-five-Year Follow-up of a Prospective Randomized Trial Comparing Preoperative Versus Postoperative FLAC/Granulocyte Colony–Stimulating Factor Chemotherapy for Stage II Breast Cancer

American Journal of Clinical Oncology(2020)10.1097/coc.0000000000000667

N/A

0DataRank · unranked

0 citations

Kenneth H. Cowan, Seth M. Steinberg, Kevin Camphausen, Craig D. Shriver, Maria J. Merino +4 more

Phase I/II study of T-DM1 alone versus T-DM1 and metronomic temozolomide in secondary prevention of HER2-positive breast cancer brain metastases following stereotactic radiosurgery.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps2572

N/A

0DataRank · unranked

0 citations

Seth M. Steinberg, DeeDee Kay Smart, Mark R. Gilbert, Terri S. Armstrong, Eric Burton +9 more

Randomized phase II trial of topotecan plus M6620 (VX-970) versus topotecan alone in patients with relapsed small-cell neuroendocrine cancers including small cell lung cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps3653

N/A

0DataRank · unranked

0 citations

Rasa Vilimas, Samantha Nichols, Linda Sciuto, Santhana Webb, Seth M. Steinberg +3 more

Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL

Journal of Clinical Oncology(2021)10.1200/jco.21.01405

N/A

0DataRank · unranked

206 citations

Agne Taraseviciute, Seth M. Steinberg, Adam J. Lamble, Jennifer Sheppard, Bonnie Yates +23 more

Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress

Cancer Cell(2021)10.1016/j.ccell.2021.02.014

N/A

0DataRank · unranked

178 citations

Nobuyuki Takahashi, Vinodh N. Rajapakse, Xiaohu Zhang, Yilun Sun, Michele Ceribelli +36 more

Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair–targeted therapies

Science Translational Medicine(2021)10.1126/scitranslmed.abc7488

N/A

0DataRank · unranked

73 citations

Nobuyuki Takahashi, Lőrinc Sándor Pongor, Vinodh N. Rajapakse, Manoj Tyagi, Xinyu Wen +20 more

Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days

Blood Advances(2021)10.1182/bloodadvances.2021004896

N/A

0DataRank · unranked

73 citations

Bonnie Yates, Seth M. Steinberg, Shilpa Shahani, John C. Molina, Tara N. Palmore +10 more

Phase 2 Study of Olaparib in Malignant Mesothelioma and Correlation of Efficacy With Germline or Somatic Mutations in BAP1 Gene

JTO Clinical and Research Reports(2021)10.1016/j.jtocrr.2021.100231

N/A

0DataRank · unranked

57 citations

Idrees Mian, Cathy Wagner, Yvonne Mallory, Maria Agra, Betsy Morrow +7 more

Safety, Activity, and Long-term Outcomes of Pomalidomide in the Treatment of Kaposi Sarcoma among Individuals with or without HIV Infection

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-3364

N/A

0DataRank · unranked

52 citations

Mark N. Polizzotto, Kathryn Lurain, Kathleen M. Wyvill, Anaida Widell, Jomy George +6 more

Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical Efficacy

Frontiers in Oncology(2021)10.3389/fonc.2021.789078

N/A

0DataRank · unranked

28 citations

Brittni N. Moore, Hadi Bagheri, Seth M. Steinberg, Jon R. Inglefield, Kim Dunham +16 more

Donor source and post‐transplantation cyclophosphamide influence outcome in allogeneic stem cell transplantation for GATA2 deficiency

British Journal of Haematology(2021)10.1111/bjh.17840

N/A

0DataRank · unranked

31 citations

Mark Parta, Nirali N. Shah, Jennifer Cuellar‐Rodríguez, Thomas R. Bauer, Robert R. West +7 more

Improving the Odds in Advanced Breast Cancer With Combination Immunotherapy: Stepwise Addition of Vaccine, Immune Checkpoint Inhibitor, Chemotherapy, and HDAC Inhibitor in Advanced Stage Breast Cancer

Frontiers in Oncology(2021)10.3389/fonc.2020.581801

N/A

0DataRank · unranked

22 citations

Sofia R. Gameiro, Yohei Ozawa, Karin M. Knudson, Kristin C. Hicks, Claudia Palena +10 more

Clinical Indicators for Long-Term Survival with Immune Checkpoint Therapy in Advanced Hepatocellular Carcinoma

Journal of Hepatocellular Carcinoma(2021)10.2147/jhc.s311496

N/A

0DataRank · unranked

18 citations

Changqing Xie, Seth M. Steinberg, Tim F. Greten, Cecilia Monge

Subsequent Cancers in Patients Affected with Moderate or Severe Chronic Graft-versus-Host Disease

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.08.001

N/A

0DataRank · unranked

10 citations

Filip Pirsl, Noa G. Holtzman, Seth M. Steinberg, Jeannette Nashed, Claire Ruben +10 more

Tolerability of Coronavirus Disease 2019 Vaccines, BNT162b2 and mRNA-1273, in Patients With Thymic Epithelial Tumors

JTO Clinical and Research Reports(2021)10.1016/j.jtocrr.2021.100229

N/A

0DataRank · unranked

8 citations

Shannon Swift, Cristina Mullenix, Yvonne Mallory, Chen Zhao, Éva Szabó +6 more

Final results from a phase I trial and expansion cohorts of cabozantinib and nivolumab (CaboNivo) alone or with ipilimumab (CaboNivoIpi) for metastatic genitourinary tumors.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.3

N/A

0DataRank · unranked

9 citations

Daniel M. Girardi, Scot A. Niglio, Rosa Maria Nadal, Lisa M. Cordes, Seth M. Steinberg +15 more

Phase I study of mesothelin-targeted immunotoxin LMB-100 in combination with tofacitinib in persons with pancreatobiliary cancer or other mesothelin expressing solid tumors.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.tps452

N/A

0DataRank · unranked

5 citations

Mehwish Ahmad, Seth M. Steinberg, Cody J. Peer, William D. Figg, David J. FitzGerald +4 more

483 Initial safety results and immune responses induced by a novel human papillomavirus (HPV)-specific gorilla adenovirus immunotherapy vaccine, PRGN-2009, in patients with advanced HPV-associated cancers

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.483

N/A

0DataRank · unranked

3 citations

Julius Strauss, Clint Allen, Renee N. Donahue, Caroline Jochéms, Seth M. Steinberg +11 more

Predictors of hematologic malignancy relapse in patients with advanced chronic graft-versus-host disease

Bone Marrow Transplantation(2021)10.1038/s41409-021-01211-2

N/A

0DataRank · unranked

0 citations

Filip Pirsl, Seth M. Steinberg, Noa G. Holtzman, Laura Parsons-Wandell, Judy Baruffaldi +10 more

A pilot clinical trial of genomic-based therapy assignment with co-expression extrapolation (COXEN) in advanced/metastatic urothelial carcinoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.452

N/A

0DataRank · unranked

0 citations

Rosa Maria Nadal, Lisa M. Cordes, Seth M. Steinberg, Nicole N. Davarpanah, Rene Costello +12 more

Reply to K. Takada et al.

JTO Clinical and Research Reports(2021)10.1016/j.jtocrr.2021.100250

N/A

0DataRank · unranked

0 citations

Cristina Mullenix, Éva Szabó, Seth M. Steinberg, Arun Rajan, Madison Ballman

A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer

The Oncologist(2022)10.1093/oncolo/oyab046

N/A

0DataRank · unranked

51 citations

Yo-Ting Tsai, Benjamin A. Weinberg, Renee N. Donahue, Shruti U. Gandhy, Margaret E. Gatti‐Mays +14 more

The impact of race, ethnicity, and obesity on CAR T-cell therapy outcomes

Blood Advances(2022)10.1182/bloodadvances.2022007676

N/A

0DataRank · unranked

48 citations

John A. Ligon, Paul Borgman, Seth M. Steinberg, Toni Foley, Lauren Little +10 more

Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1663

N/A

0DataRank · unranked

28 citations

Hyun Jung, G. Thomas Brown, Yanling Liu, Ben Somerville, Curtis Lisle +20 more

Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.01.021

N/A

0DataRank · unranked

22 citations

Steven Z. Pavletic, Stephanie J. Lee, Paul J. Martin, Don Farthing, Frances T. Hakim +13 more

Current status of National Institutes of Health funding for thoracic surgeons in the United States: Beacon of hope or candle in the wind?

Journal of Thoracic and Cardiovascular Surgery(2022)10.1016/j.jtcvs.2022.10.011

N/A

0DataRank · unranked

1 citations

Umay Tuana Tolunay, Lindsay A. Demblowski, Haitao Wang, Shamus R. Carr, Chuong D. Hoang +5 more

Seth M. Steinberg

Indexed papers

Top data-sharing exemplar

Papers